Correlation between lupus anticoagulants and anticardiolipin antibodies in patients with prolonged activated partial thromboplastin times
- 1 February 1990
- journal article
- research article
- Published by Elsevier in The American Journal of Medicine
- Vol. 88 (2) , 112-116
- https://doi.org/10.1016/0002-9343(90)90458-p
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Prolonged activated partial thromboplastin time of unknown etiology: A prospective study of 100 consecutive cases referred for consultationAmerican Journal of Hematology, 1988
- Immunological specificity and mechanism of action of IgG lupus anticoagulantsBlood, 1987
- STANDARDISING THE ANTI-CARDIOLIPIN ANTIBODY TESTThe Lancet, 1987
- Thrombosis, Recurrent Fetal Loss, and ThrombocytopeniaArchives of internal medicine (1960), 1986
- Significance of the lupus anticoagulantAmerican Journal of Hematology, 1986
- Circulating Anticoagulant in Systemic Lupus erythematosus: Clinical ManifestationsActa Haematologica, 1986
- Lupus anticoagulant: An analysis of the clinical and laboratory features of 219 casesAmerican Journal of Hematology, 1985
- ANTICARDIOLIPIN ANTIBODIES: DETECTION BY RADIOIMMUNOASSAY AND ASSOCIATION WITH THROMBOSIS IN SYSTEMIC LUPUS ERYTHEMATOSUSThe Lancet, 1983
- Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating lupus anticoagulant.BMJ, 1983
- Monoclonal immunoglobulin M lambda coagulation inhibitor with phospholipid specificity. Mechanism of a lupus anticoagulant.Journal of Clinical Investigation, 1980